Kao Steven C - Department of Medical Oncology, Chris O'Brien Lifehouse

基本信息

浏览量：26

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 270 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Coupling of Response Biomarkers Between Tumor and Peripheral Blood in Patients Undergoing Chemoimmunotherapy

Wee Loong Chin,Alistair M. Cook,Jonathan Chee,Nicola Principe, Tracy S. Hoang,Joel Kidman,Khaing P. W. Hmon,Yen Yeow,Matthew E. Jones,Rui Hou,Elena Denisenko,Alison M. Mcdonnell,Chung-Chau Hon,Jonathan Moody,Denise Anderson,Sonia Yip,Michelle M. Cummins,Martin R. Stockler,Peey-Sei Kok,Chris Brown,Thomas John,Steven C. -H. Kao,Deme J. Karikios, Kenneth J. O'Byrne,Brett G. M. Hughes, Richard A. Lake, Alistair R. R. Forrest,Anna K. Nowak, Timo Lassmann,W. Joost Lesterhuis

CELL REPORTS MEDICINE（2025）

引用0浏览0WOS引用

First-in-human Phase 1 Dose-Escalation Results with Livmoniplimab, an Antibody Targeting the GARP:TGF-ß1 Complex, As Monotherapy and in Combination with the Anti-Pd-1 Antibody Budigalimab in Patients with Advanced Solid Tumors

Toshio Shimizu,John Powderly,Albiruni Abdul Razak,Patricia Lorusso,Kathy D. Miller,Steven Kao,Sarah Kongpachith, Catherine Tribouley, Michelle Graham, Brian Stoll,Maulik Patel,Mohammad Sahtout,Martha Blaney,Rachel Leibman,Talia Golan,Anthony Tolcher

Frontiers in Oncology（2025）

引用0浏览0WOS引用

A Combination of PD-1 and TIGIT Immune Checkpoint Inhibitors Elicits a Strong Anti-Tumour Response in Mesothelioma

Huaikai Shi,Ta-Kun Yu, Ben Johnson, Sakthi Priya Selvamani,Ling Zhuang,Kenneth Lee,Sonja Klebe,Samuel Smith,Kirby Wong, Kate Chen,Georgina Clark,Emma M. Rath, Holly Pearson,David Gallego Ortega,Anthony Linton,Steven Kao,Pablo Silveira,Yuen Yee Cheng

Journal of Experimental & Clinical Cancer Researchno. 1 (2025): 1-13

引用0浏览0WOS引用

Corrigendum: First-in-human Phase 1 Dose-Escalation Results with Livmoniplimab, an Antibody Targeting the GARP: TGF-ß1 Complex, As Monotherapy and in Combination with the Anti-Pd-1 Antibody Budigalimab in Patients with Advanced Solid Tumors

Toshio Shimizu,John Powderly,Albiruni Abdul Razak,Patricia LoRusso,Kathy D Miller,Steven Kao,Sarah Kongpachith, Catherine Tribouley, Michelle Graham, Brian Stoll,Maulik Patel,Mohammad Sahtout,Martha Blaney,Rachel Leibman,Talia Golan,Anthony Tolcher

Frontiers in oncology (2025): 1544394-1544394

引用0浏览0WOS引用

Durvalumab Consolidation after Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Experience from the Australian Subset of PACIFIC-R

Ben Markman,Steven Kao,Nick Pavlakis,Victoria Bray, Leisl Packer,Shankar Siva

Cancer treatment and research communications (2025): 100929-100929

引用0浏览0WOS引用

Five-year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: IMbrella A Extension Study Results

Wolfgang Schuette,Stephen Liu,Rafal Dziadziuszko,Shunichi Sugawara,Steven Kao,Maximilian Hochmair,Florian Huemer,Gilberto Castro,Libor Havel,Reyes Bernabe Caro,Gyorgy Losonczy, Jong-Seok Lee, Dariusz Kowalski,Zoran Andric,Raffaele Califano, Andrea Veatch, Gregory Gerstner,Marta Batus,Stefanie Morris,Monika Kaul, Madeena Siddiqui, Huafei Li, Wei Zhang,Barzin Nabet,Martin Reck

ONCOLOGY RESEARCH AND TREATMENT (2024): 124-125

引用0浏览0引用

BGB-LC-201 (NCT05635708): A Phase 2, Open-Label, Multi-Arm Study of Tislelizumab (TIS; Anti-Pd-1) in Combination with Investigational Agents Plus /- Chemotherapy As First-Line Treatment for Patients with Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

George Blumenschein,Benjamin Besse,Justin F. Gainor, DingZhi Huang,Steven Kao, Se-Hoon Lee, Luis Paz-Ares,Xin Chen, Wanyu He, Sridharan Gururangan,Kathy Zhang,Caicun Zhou

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Abstract CT277: BGB-LC-201 (NCT05635708): A Phase 2, Open-Label, Multi-Arm Study of Tislelizumab (TIS; Anti-Pd-1) in Combination with Investigational Agents +/- Chemotherapy As First-Line Treatment for Patients with Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

George Blumenschein,Benjamin Besse,Justin F. Gainor,DingZhi Huang,Steven Kao,Se-Hoon Lee,Luis Paz-Ares, Xin Chen, Wanyu He, Sridharan Gururangan,Kathy Zhang,Caicun Zhou

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Real-world Outcomes of Advanced Head and Neck Squamous Cell Carcinoma in Patients Receiving Pembrolizumab: an Australian Single-Centre Experience

Claudia Leslie,Michael Boyer,Jenny H. Lee,Steven Kao,Mun Hui

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2024): 48-49

引用0浏览0引用

Five-year Survival in Patients with Extensive-Stage Small Cell Lung Cancer Treated with Atezolizumab in the Phase III IMpower133 Study and the Phase III IMbrella a Extension Study

Martin Reck,Rafal Dziadziuszko,Shunichi Sugawara,Steven Kao,Maximilian Hochmair,Florian Huemer,Gilberto de Castro Jr,Libor Havel,Reyes Bernabe Caro,Gyorgy Losonczy,Jong-Seok Lee,Dariusz M. Kowalski,Zoran Andric,Raffaele Califano, Andrea Veatch, Gregory Gerstner,Marta Batus,Stefanie Morris,Monika Kaul,Vaikunth Cuchelkar, Huafei Li, Bradford J. Danner,Barzin Y. Nabet,Stephen Liu

Lung Cancer (2024): 107924-107924

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn